Drug Discovery · Kent, United Kingdom · Founded 2021 · Privately Held (backing)
Developer of a novel medicines platform designed to treat neurological disorders. Pangea Bio is based in Kent, United Kingdom and was founded in 2021. It was valued at $80 million at its early-stage round in Oct 2024, the last priced event on record. It has raised $21.7 million across 1 recorded round; the latest was a $15.6 million Series A in Oct 2023.
PMV mark · valuation
$80.0M
Oct 2026
Priced at
its early-stage round
Oct 2024
Total raised
$21.7M
Last round
Early Stage VC (Series A)
Oct 2023
Team — not yet on record
No current team members for Pangea Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Pangea Bio with a free account
·The complete investor list: 19 names
·Watch Pangea Bio: the Monday email on marks, rounds and moves
